XDND:F:F-Xtrackers MSCI North America High Dividend Yield UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 48.38

Change

-0.12 (-0.25)%

Market Cap

USD 0.11B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.18 (-0.35%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.28%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.32%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.29 (+0.31%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.80%)

USD 45.80B
0ZC:F Zscaler Inc

-3.20 (-1.54%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.35%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing XDND:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.02% 27% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.02% 27% F 43% F
Trailing 12 Months  
Capital Gain 0.44% 38% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.44% 36% F 47% F
Trailing 5 Years  
Capital Gain 54.40% 57% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.40% 57% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 12.19% 78% C+ 70% C-
Dividend Return 12.19% 76% C+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.04% 60% D- 89% A-
Risk Adjusted Return 110.45% 96% N/A 96% N/A
Market Capitalization 0.11B 33% F 32% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.